| 764288 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
2 Quantitation of CD137 and Nectin-4 expression across multiple tumor types to support indication selection for BT7480, a Bicycle tumor-targeted immune cell agonist™ (Bicycle TICA™) |
2021-11-01 |
10.1136/jitc-2021-sitc2021.002 |
Cohen Heather, Campbell Carly, Hurov Kristen, Lahdenranta Johanna, Gelb Tara, Galbraith David, Rozelle Dan, Nagy Mate, Au Qingyan, Parnell Erinn, Brandish Phil, Hazard Sebastien, Smethurst Dominic, Keen Nicholas, Blakemore Stephen |
| 764287 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
1 Dissecting β-catenin associated inflammation in patients with desmoid fibromatosis to identify prognostic biomarkers |
2021-11-01 |
10.1136/jitc-2021-sitc2021.001 |
Bergamaschi Laura, Perrone Federica, Rini Francesca, Rivoltini Licia, Castelli Chiara, Gronchi Alessandro, Colombo Chiara, Vallacchi Viviana |
| 764286 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
736 Treatment with decitabine (DAC) induces the expression of stemness markers, PD-L1 and NY-ESO-1 in colorectal cancer |
2021-11-01 |
10.1136/jitc-2021-sitc2021.736 |
Taib Nassiba, Merhi Maysaloun, Inchakalody Varghese, Mestiri Sarra, Raza Afsheen, Uddin Shahab, Maccalli Cristina, AlHomsi Mohammed Ussama, Dermime Said |
| 764285 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
735 Identification of a small molecule that prevents T cell exhaustion using machine learning algorithms paired with high-resolution single cell RNAseq |
2021-11-01 |
10.1136/jitc-2021-sitc2021.735 |
Mercier Isabelle Le, Sun Sunny, Xiao Dongmei, Isacco Laura, Treacy Daniel, Artru Emilie, Steelman Scott, Bradley John, Wolf Alex, Stewart Morag, Tozzo Effie |
| 764284 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
734 BET inhibitors synergize with anti-PD1 by rescuing TCF1+ progenitor exhausted T cells in acute myeloid leukemia |
2021-11-01 |
10.1136/jitc-2021-sitc2021.734 |
Romine Kyle, Cho Hyun-Jun, Kosaka Yoko, Byrd Kaelan, Coy Jesse, Flynn Patrick, Newman Matthew, Loo Christopher, Lind Evan |
| 764283 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
733 Immunological mechanisms of resistance to CDK4/CDK6 inhibitors in breast cancer |
2021-11-01 |
10.1136/jitc-2021-sitc2021.733 |
Petroni Giulia, Gouin Kenneth, Martinez Aitziber Buqué, Knott Simon, Formenti Silvia, Galluzzi Lorenzo |
| 764282 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
732 A novel nuclear receptor 4A1 (NR4A1) antagonists attenuates T-cell exhaustion in colorectal cancer |
2021-11-01 |
10.1136/jitc-2021-sitc2021.732 |
Mohankumar Kumaravel, Wright Gus, Kumaravel Subhashree, Shrestha Rupesh, Abdelrahim Maen, Chapkin Robert, Safe Stephen |
| 764281 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
731 Concurrent immunotherapy and dipeptidyl peptidase-4 inhibition among patients with solid tumors |
2021-11-01 |
10.1136/jitc-2021-sitc2021.731 |
Miranda Kayla, Tucker Matthew, Chen Yu-Wei, Beckermann Kathryn, Rini Brian |
| 764280 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
730 Hypoxia reduction in tandem with anti-angiogenic therapy remodels the PDAC microenvironment and potentiates CD40 agonist therapy |
2021-11-01 |
10.1136/jitc-2021-sitc2021.730 |
Liu Arthur, Curran Michael |
| 764279 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
727 Resistance to enzalutamide and abiraterone drives tumor phenotypic plasticity and resistance to immune-mediated cytotoxicity |
2021-11-01 |
10.1136/jitc-2021-sitc2021.727 |
Dahut Madeline, Fousek Kristen, Horn Lucas, Qin Haiyan, Schlom Jeffrey, Palena Claudia |
